Diglycidic ether derivative therapeutics and methods for their use

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9862667
SERIAL NO

12999037

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This invention provides compound having a structure of Formula I or Formula II. Uses of such compounds for treatment of various indications, including prostate cancer as well as methods of treatment involving such compounds are also provided.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BRITISH COLUMBIA CANCER AGENCY BRANCH675 WEST 10TH AVENUE VANCOUVER BRITISH COLUMBIA V5Z 1L3

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Andersen, Raymond J Vancouver, CA 25 224
Leblanc, Mike Vancouver, CA 39 179
Mawji, Nasrin R Burnaby, CA 25 319
Sadar, Marianne D West Vancouver, CA 8 169
Wang, Jun New Westminster, CA 2215 18848
Williams, David E Vancouver, CA 46 1774

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 9, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 9, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00